# Musculoskeletal Sarcoidosis With Sacroiliac Involvement: Report of a Rare Case

**Authors:** Mohamed Nassiri, Abdessamad Laaribi, Abdessalam Achkoun, Rachid Chafik

PMC · DOI: 10.7759/cureus.99759 · Cureus · 2025-12-21

## TL;DR

A rare case of sarcoidosis affecting the musculoskeletal system, including the sacroiliac joints, is reported with MRI findings and successful corticosteroid treatment.

## Contribution

This paper presents a rare clinical case of musculoskeletal sarcoidosis with sacroiliac involvement and highlights the importance of histopathological confirmation.

## Key findings

- MRI revealed bilateral sacroiliitis and pseudotumoral muscle lesions in a patient with musculoskeletal sarcoidosis.
- Histopathological analysis confirmed non-caseating granulomas, leading to a sarcoidosis diagnosis.
- Treatment with oral prednisone resulted in significant clinical improvement.

## Abstract

Sarcoidosis is a systemic granulomatous disease of unknown etiology that rarely affects the musculoskeletal system. Sacroiliac involvement is exceptional and may mimic spondyloarthropathies or malignancy. We report the case of a 47-year-old man presenting with progressive bilateral sacroiliac and shoulder pain. MRI showed bilateral sacroiliitis with diffuse bone marrow lesions in the pelvic girdle and femoral heads, as well as a pseudotumoral lesion of the iliopsoas muscle. CT demonstrated a lytic lesion of the left humeral head with cortical rupture. Laboratory findings revealed elevated C-reactive protein, hypercalciuria, and increased serum angiotensin-converting enzyme (ACE) levels. Histopathological examination of bone and muscle biopsies demonstrated non-caseating granulomas. The diagnosis of musculoskeletal sarcoidosis was established. The patient was treated with oral prednisone (1 mg/kg/day), leading to marked clinical improvement. Sacroiliac sarcoidosis is an unusual presentation requiring careful exclusion of infectious and inflammatory disorders. MRI is useful for detecting bone and muscle lesions, but histological confirmation remains essential. Corticosteroid therapy is effective in most cases, though close monitoring is required.

## Linked entities

- **Chemicals:** prednisone (PubChem CID 5865)
- **Diseases:** sarcoidosis (MONDO:0008399)

## Full-text entities

- **Genes:** ACE (angiotensin I converting enzyme) [NCBI Gene 1636] {aka ACE1, CD143, DCP, DCP1}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}
- **Diseases:** bone and muscle lesions (MESH:D001847), sacroiliac and shoulder pain (MESH:D020069), cortical rupture (MESH:D012421), lesion (MESH:D009059), spondyloarthropathies (MESH:D025242), bone marrow lesions (MESH:D001855), inflammatory disorders (MESH:D007249), hypercalciuria (MESH:D053565), Musculoskeletal Sarcoidosis (MESH:D012507), Sacroiliac Involvement (MESH:C563037), granulomatous disease (MESH:D006105), infectious (MESH:D003141), malignancy (MESH:D009369), sacroiliitis (MESH:D058566), granulomas (MESH:D006099)
- **Chemicals:** prednisone (MESH:D011241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12817229/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12817229/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12817229/full.md

---
Source: https://tomesphere.com/paper/PMC12817229